Angela Johnson, PhD, RAC, CPGP is the Head of Global Regulatory and Compliance at Cytiva, overseeing product regulatory compliance, communications with regulatory agencies and customer regulatory project execution. In her career she had held leadership positions in biopharmaceutical development and regulatory affairs, including leading the regulatory affairs function of two venture-backed biotech companies through successful IPO and exit, including in complex genetically modified cell therapies. In addition, she has served as a senior leader in multiple consulting roles, leading global regulatory teams across the globe to support customers. Angela holds a Masters Materials Science and Engineering from North Carolina State University (NCSU) and a PhD in Biomedical Communications from Texas Tech University (TTU) specializing in global expert and investor communications in venture-backed biotech organizations. She also holds multiple certifications in drug development and biotechnology venture financing. She has published over 20 peer-reviewed papers in medical technologies and regulatory affairs, and previously served on multiple boards at American Society of Cell and Cene Therapy (ASGCT) and other industry organizations, and currently supports the Boston drug development community by serving as faculty on the Northeastern University’s regulatory affairs master’s program.